Dupont Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,374
Closed -$76.3K 489
2023
Q2
$76.3K Sell
6,374
-725
-10% -$8.18K ﹤0.01% 454
2023
Q1
$83.1K Sell
7,099
-55,644
-89% -$812K ﹤0.01% 511
2022
Q4
$1.06M Buy
62,743
+2,230
+4% +$36.8K 0.05% 311
2022
Q3
$707K Buy
+60,513
New +$865K 0.04% 514
2020
Q1
Sell
-36,958
Closed -$388K 1359
2019
Q4
$388K Sell
36,958
-5,077
-12% -$45.9K 0.01% 960
2019
Q3
$359K Buy
42,035
+2,391
+6% +$23.4K 0.01% 923
2019
Q2
$456K Sell
39,644
-1,800
-4% -$23.2K 0.01% 829
2019
Q1
$581K Buy
+41,444
New +$543K 0.01% 707
2018
Q2
Sell
-45,900
Closed -$804K 1023
2018
Q1
$804K Sell
45,900
-18,944
-29% -$395K 0.02% 576
2017
Q4
$1.49M Buy
64,844
+55,200
+572% +$1.14M 0.03% 424
2017
Q3
$202K Sell
9,644
-54,600
-85% -$1.01M ﹤0.01% 799
2017
Q2
$1.3M Sell
64,244
-32,458
-34% -$707K 0.03% 471
2017
Q1
$2.35M Buy
96,702
+73,900
+324% +$1.99M 0.05% 318
2016
Q4
$614K Buy
+22,802
New +$563K 0.01% 614
2013
Q3
Sell
-141,790
Closed -$2.74M 632
2013
Q2
$2.74M Buy
+141,790
New +$3.09M 0.05% 309

Other funds holding PTEN

Dupont Capital Management's PTEN Position: Q3 2023 in Review

Dupont Capital Management sold out of Patterson-UTI (PTEN) in Q3 2023, closing a stake of 6,374 shares — an estimated $76.3K sold.

Dupont Capital Management first reported a position in PTEN in Q2 2013 and held it in 15 quarters. The position peaked at $2.74M in Q2 2013. 357 funds tracked by Wall St. Rank hold PTEN as of Q3 2023.

  • Dupont Capital Management reported no remaining Patterson-UTI position as of Q3 2023 after selling out during the quarter.
  • Dupont Capital Management sold 6,374 Patterson-UTI shares in Q3 2023, an estimated $76.3K.
  • Dupont Capital Management first reported a position in Patterson-UTI in Q2 2013 and held it in 15 quarters.
  • Dupont Capital Management's Patterson-UTI position peaked at $2.74M in Q2 2013.
  • 357 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2023.

Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.